Jenei Alex, Tzankov Alexandar
Department of Pathology and Experimental Cancer Research Semmelweis University, Faculty of Medicine, Budapest, Hungary.
Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
Am J Clin Pathol. 2025 Mar 8;163(3):395-405. doi: 10.1093/ajcp/aqae133.
Leukemia cutis is a conflicting term to describe neoplastic hematopoietic infiltrates in the skin. Cutaneous myeloid or lymphoid proliferations often present a serious differential diagnostic challenge for pathologists.
This review aims to outline the confusion associated with the term leukemia cutis and discuss in detail the foremost common differential diagnoses in daily practice. The review is based on a summary of the relevant literature as well as on the authors' experience.
It addresses precursor cell myeloid and lymphoid tumors that are strictly considered true leukemia cutis but also more mature neoplasms, including some recently described mature extramedullary myeloid proliferations. Finally, a practical, comprehensive stepwise approach combining traditional immunohistochemical marker panels, novel lineage- or mutational-specific markers, and other ancillary tests is suggested to reach an entity-specific diagnosis.
The proper combination of ancillary techniques can help the pathologist to provide an accurate diagnosis of these challenging skin lesions.
皮肤白血病是一个用于描述皮肤中肿瘤性造血浸润的存在争议的术语。皮肤髓系或淋巴系增殖性病变常常给病理学家带来严峻的鉴别诊断挑战。
本综述旨在概述与皮肤白血病这一术语相关的混淆之处,并详细讨论日常实践中最常见的鉴别诊断。该综述基于相关文献的总结以及作者的经验。
它涉及严格意义上被视为真正皮肤白血病的前体细胞髓系和淋巴系肿瘤,也包括更成熟的肿瘤,其中一些是最近描述的成熟髓外髓系增殖性病变。最后,建议采用一种实用、全面的逐步方法,结合传统免疫组化标志物组合、新型谱系或突变特异性标志物以及其他辅助检查,以实现实体特异性诊断。
辅助技术的恰当组合有助于病理学家对这些具有挑战性的皮肤病变做出准确诊断。